ImmunoGen
Why Robinhood?
You can watch ImmunoGen and buy or sell other stocks, ETFs, and their options commission-free!About IMGN
ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151.
IMGN Key Statistics
Stock Snapshot
The current ImmunoGen(IMGN) stock price is $31.23, with a market capitalization of 8.72B. The stock trades at a price-to-earnings (P/E) ratio of -104.24.
ImmunoGen(IMGN) stock opened on 2026-04-01 at —. The price climbed to — and dipped to —.
The ImmunoGen(IMGN)'s current trading volume is 0, compared to an average daily volume of 10.88M.
During the past year, ImmunoGen(IMGN) stock moved between $3.61 at its lowest and $31.25 at its peak.
During the past year, ImmunoGen(IMGN) stock moved between $3.61 at its lowest and $31.25 at its peak.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.